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Detection of malnutrition in dialysis patients is important
since this is a predictor of morbidity and mortality. Lean body
mass (LBM) reflects the somatic protein store and this was
measured by creatinine kinetics, anthropometry, and
biometric impedance in 210 incident Chinese patients on
continuous ambulatory peritoneal dialysis. The study was
started in the third month of dialysis and the patients were
followed for an average of 29 months. We devised three
models of survival by combining the three different LBM
measures with several nutritional markers and recognized
outcome predictors. Follow-up was censored for
transplantation or transfer to hemodialysis with an end point
of death while on peritoneal dialysis. Statistical correlations
were observed among the LBM values determined by all the
three methods and these correlated significantly with both
left and right hand grip strength but not with nutritional
markers. LBM by creatinine kinetics, mean arterial pressure,
and the calcium–phosphorus product were significant,
independent predictors of death in one survival model.
Anthropometry and bioelectric impedance were not
significant predictors of death in the other two models.
Our study suggests that LBM measured by creatinine kinetics,
anthropometry, and bioelectrical impedance correlates well
with the somatic protein store but not with the general
nutritional status.
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It is well known that the early detection and diagnosis of
malnutrition is critical in continuous ambulatory peritoneal
dialysis (CAPD) patients since malnutrition is associated
with high morbidity and mortality.1,2 Lean body mass
(LBM), which reflects the somatic protein store, is commonly
used as a nutritional index for CAPD patients. The gold
standard of LBM is the total body water (TBW) multiplied by
0.73, where the total body water is equal to the antipyrine
distribution volume measured by using the tracer dilution
method.3 However, this method is laborious, invasive, and
unsuitable for routine patient care. Therefore, noninvasive
and indirect methods for measuring LBM, such as creatinine
kinetics (LBM-CK), anthropometry (LBM-A), bioelectrical
impedance (LBM-BEI), and dual-energy X-ray absorptio-
metry are increasingly applied for CAPD patients.
Although some studies have reported LBM measurement
by simultaneously using two or three of the above-mentioned
methods to evaluate the nutritional status of peritoneal
dialysis (PD) patients,4–21 few studies have considered
whether LBM measured using different methods is related
to other nutritional indicators. Keshaviah et al.6 observed
that LBM measured by CK correlated with the serum
albumin (Alb), Scr, and nPCR levels, and they considered
LBM-CK as a simple and convenient general nutritional
index. However, Szeto et al.7 reported that LBM-A and LBM-
CK were poorly correlated with other nutritional indices, and
they highlighted the importance of using multiple markers
for assessing the various aspects of a patient’s nutritional
status. Further, Heimburger et al.8 also did not observe good
correlations of LBM-AM and LBM-CK with serum Alb. Thus,
whether LBM measured by different methods is a general
nutritional index remains unclear.
Conversely, LBM has not been adequately studied as a
potential predictor of death, specifically among CAPD
patients. Many logistic regression survival models involving
PD patients did not include LBM in the analysis. To our
knowledge, Heimburger et al.,8 Trivedi et al.,9 Szeto et al.,10
and Chung et al.11 used LBM-CK as a variable in survival
analysis; however, not all authors demonstrated that
LBM-CK is a strong negative predictor of death in CAPD
patients. Further, whether LBM-A and LBM-BEI can predict
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the outcome of CAPD patients has not been determined to
date.
To our knowledge, the above-mentioned analyses regard-
ing the correlations of LBM with other nutritional indicators
and with the outcome of PD were not adjusted by sex,
inflammation, and volume overload. However, the predictive
power of various nutritional markers differed considerably
between male and female patients.12 Inflammation and
volume overload are widely accepted as factors influencing
the measurement of nutritional indices, particularly the
visceral protein store, in PD patients.22–24 Further, it is well
known that volume overload can influence the LBM-BEI and
LBM-A measurements.13,14 In this study, we aim to identify
whether LBM-CK, LBM-A, and LBM-BEI can reflect the
general nutritional status adjusted by sex, inflammation, and
volume status. Further, we aim to determine whether these
measurements can predict the outcome of PD while
considering certain recognized factors such as age, diabetes
mellitus (DM), cardiovascular disease (CVD), inflammation,
and volume status by performing retrospective and survival
analyses on a large population of Chinese CAPD patients.
RESULTS
The patient demographics, etiology of renal disease, clinical
characteristics, and biochemical parameters are summarized
in Table 1. The mean duration of follow-up on PD was
29±12 months. The outcomes were as follows: 30 of 210
patients died; four were transferred to hemodialysis; 11 had
to undergo renal transplants; and 165 continued PD.
Subjective global assessment (SGA) on enrollment, that is,
in the third month of PD, revealed that 36 patients (17.14%)
were malnourished. The values (%) of LBM-CK, LBM-A, and
LBM-BEI in the patients are shown in Table 2.
Our CAPD patients were divided into two groups
depending on whether their serum C-reactive protein
(CRP) levels were above or below 3 mg l1. Patients with
CRPX3 mg l1 exhibited significantly lower dietery energy
intake, dietery protein intake (DPI), and prealbumin (PA)
values and a higher incidence of malnutrition diagnosed by
SGA (Po0.05; Table 3). Partial correlation analysis revealed
that the LBM-CK, LBM-A, and LBM-BEI values all correlated
significantly with the hand grip strength (HGS) (R and L;
P¼ 0.000 for both) but not with the Alb, PA, transferrin, DPI
and dietery energy intake, and SGA (P40.05) adjusted by
sex, CRP, and ECW/TBW (ECW, extracellular water). LBM-
CK, LBM-A, and LBM-BEI correlated each other signifi-
cantly, with r values ranging from 0.72 to 0.89 (P¼ 0.000).
All correlations are shown in Table 4.
Table 5 depicts the baseline and ‘enrollment’ variables that
were observed to be independently associated with death in
the three models (Po0.05). The stepwise procedure revealed
that LBM-CK (P¼ 0.035) and mean arterial pressure (MAP)
(P¼ 0.027) were negatively associated, while cCaP (product
of corrected calcium and phosphate) (P¼ 0.016) was
positively associated with the risk of death in model 1. In
models 2 and 3, cCaP (P¼ 0.022 and P¼ 0.024 respectively)
and MAP (P¼ 0.004 for both models) were both significantly
associated with the risk of death. Table 6 lists all the variables
that were excluded for the three models, of which LBM-A
and LBM-BEI were not significant predictors of death in
models 2 and 3, respectively.
DISCUSSION
LBM, a marker of the somatic protein store, is a critical
parameter for evaluating the nutritional status of PD
Table 1 | Demographics, etiology of end-stage renal disease,
clinical characteristics, and biochemical parameters of CAPD
patients (n=210)
Age (years) 60.3±14.1
Gender (male/female) 86:124
BMI (kg m2)a 23.52±3.76
DM (n (%)) 71 (33.8)
CVD (n (%)) 64 (30.5)
Primary renal disease
DM 58
Hypertension 56
Glomerulonephritis 58
Tubulointerstitial nephritis 27
Lupus nephritis 2
Other 19
RRF (ml min1) 2.00 (0–13.55)
Urine volume (ml) 640 (0–2700)
Ultrafiltration (ml) 400 (200 to 3000)
TKt/V 1.82±0.54
Tccr(l per week per 1.73 m2) 70.66±29.41
Creatinine (mmol l1) 684.79±251.74
TG (mmol l1) 2.21±1.63
(0.32–12.1)
TCHO (mmol l1) 5.15±1.41
Corrected calcium (mmol l1) 2.71±0.50
Phosphorus (mmol l1) 1.59±0.45
Product of corrected calcium and phosphorus
(mg2 l2)
51.42±15.93
iPTH (pg ml1) 145.5 (10–2000)
CRP (mg l1) 2.1 (0.17–94.73)
SBP (mm Hg) 133.73±18.71
DBP (mm Hg) 78.16±14.13
MAP (mm Hg) 97.11±17.43
BMI, body mass index; CRP, C-reactive protein; CVD, cardiovascular disease;
DBP, diastolic blood pressure; DM, diabetes mellitus; iPTH, intact parathyroid
hormone; MAP, mean arterial pressure.RRF, residual renal function; SBP, systolic
blood pressure; Tccr, total creatine clearance rate; TCHO, total cholesterol; TG,
triglyceride; TKt/V, weekly urea clearance.
aBMI was calculated as body weight (kg)/height (m2).
Table 2 | Values of LBM-CK (%LBM-CK), LBM-BEI (%LBM-BEI),
and LBM-A (%LBM-A)
Variables Male (n=86) Female (n=124) Total (n=210)
LBM-CK(1 kg) 41.28±9.13 30.86±6.39 35.02±9.14
%LBM-CK 66.13±13.25 61.45±13.08 63.54±14.21
LBM-BEI(1 kg) 46.02±9.04 33.65±6.43 38.78±9.54
%LBM-BEI 74.14±9.24 67.23±12.10 70.00±12.01
LBM-A(1 kg) 54.90±6.19 40.79±6.29 47.50±7.16
%LBM-A 87.33±9.12 80.18±11.12 83.40±11.33
LBM-CK, lean body mass–creatinine kinetics; LBM-BEI, lean body mass-bioelectrical
impedance; LBM-A, lean body mass-anthropometry; %LBM-CK, %LBM-A, and %LBM-
BEI are LBM-CK, LBM-A, and LBM-BEI normalized to ideal body weight, respectively.
Results are shown as mean±s.e.m.
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patients. Since the antipyrine distribution volume, which is
the gold standard of LBM, cannot be widely used for
monitoring the nutritional status, certain alternative methods
for routine LBM measurement have been applied for dialysis
patients.15 LBM measured by CK, A, and BEI is often used in
clinical practice.
However, whether LBM is a general nutritional index or
only a somatic protein index has not been clarified in the few
related reports available;4–21 these studies selected 1–3
methods for measuring LBM but obtained controversial
results with regard to the correlations between LBM and
other nutritional indicators. To our knowledge, Pearson
correlation analyses were used in the above-mentioned
studies and this type of analysis is unsuitable for cases
wherein disturbing factors for measuring nutritional indica-
tors exist. The first of such disturbing factors is sex.
Stenvinkel et al.12 observed that low HGS was an excellent
independent outcome predictor in males but not in females,
and they concluded that sex must be considered in studies
related to nutrition and nutritional interventions in end-
stage renal disease patients. The second disturbing factor is
inflammation. Some authors demonstrated that indices of
the visceral protein store, such as serum Alb, PA, and
Table 3 | General nutrition parameters of CAPD patients with CRPX3 mg l1 and CRPo3 mg l1
Variables CRPX3l mg l1 (n=74) CRPo3l mg l1 (n=136) P (t, z or v)
DEI (kcal per kg per day) 26.78±6.65 29.27±6.62* 0.015
DPI (g per kg per day) 0.78±0.28 0.84±0.23* 0.034
Alb (g l1) 36.11±4.63 37.25±4.37 0.080
PA (mg per 100 ml) 213.00 (11.00–490.00) 311.00 (61.00–541.00)* 0
TF (mg per 100 ml) 346.25 (49.40–1239.20) 284.00 (9.06–1337.20) 0.372
HGS-R (n) 195.18±89.05 209.07±93.19 0.327
HGS-L (n) 211.03±99.86 224.59±96.11 0.373
SGA 2 or 3 18 (24.32%) 18 (13.23%)* 0.037
Alb, albumin; DEI, dietary energy intake; DPI, dietary protein intake; HGS-L, hand grip strength-left; HGS-R, hand grip strength-right; PA, prealbumin; SGA, subjective global
assessment; TF, transferin.
Results are shown as mean±s.e.m.; *Po0.05 compared to CRPX3 mg l1 group.
Table 4 | The relation of LBM measured by the three methods
and general nutrition indices adjusted by sex, CRP, and ECW/
TBW (n=210)
LBM-CK LBM-BEI LBM-A
SGA
r 0.17 0.17 0.19
P 0.08 0.08 0.07
Alb
r 0.06 0.05 0.04
P 0.55 0.61 0.69
PA
r 0.08 0.08 0.01
P 0.41 0.43 0.99
TF
r 0.10 0.10 0.08
P 0.34 0.32 0.42
DPI
r 0.12 0.08 0.13
P 0.25 0.44 0.21
DEI
r 0.13 0.12 0.09
P 0.21 0.19 0.34
HGS(R)
r 0.53# 0.68# 0.62#
P 0 0 0
HGS(L)
r 0.56# 0.69# 0.64#
P 0 0 0
LBM-CK
r — 0.76# 0.72#
P 0 0
LBM-BEI
r 0.76# — 0.89#
P 0 0
LBM-A
r 0.72# 0.89# —
P 0 0
Alb, albumin; DEI, dietary energy intake; DPI, dietary protein intake; HGS(L), hand
grip strength-left; HGS(R), hand grip strength-right; LBM-A, lean body mass-
anthropometry; LBM-BEI, lean body mass-bioelectrical impedance; LBM-CK, lean
body mass- creatinine kinetics; PA, prealbumin; SGA, subjective global assessment;
TF, transferin.
#Po0.001, *Po0.05 between two indices.
Table 5 | Variables at the ‘enrollment’ point of PD determined
to be associated with all-cause mortality by the multiple Cox
proportional regression analysis in three models (significance
level 0.05 or less, death=1)
b Wald P RR 95% CI for RR
Variables in model 1
LBM-CK 0.100 4.450 0.035 0.905 0.825B0.993
MAP 0.040 4.890 0.027 0.960 0.926B0.995
cCaP 0.036 5.860 0.016 1.037 1.007B1.067
Variables in model 2
MAP 0.054 8.080 0.004 0.947 0.913B0.981
cCaP 0.034 5.253 0.022 1.035 1.005B1.065
Variables in model 3
MAP 0.055 8.366 0.004 0.946 0.911B0.982
cCaP 0.034 5.105 0.024 1.035 1.005B1.065
cCap, the product of corrected calcium and phosphate; LBM-CK, lean body mass-
creatinine kinetics; MAP, mean arterial pressure.
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transferrin, were negative reactant protein during the process
of inflammation;23,24 this result was confirmed in our study
as shown in Table 3. These indices are now considered
markers of inflammation. Thus, inflammation reflected by
the serum CRP levels must be adjusted in correlation analyses
in such studies. The third disturbing factor is the fluid status.
Volume overload is known to lead to hypoalbuminemia in
patients. In addition, the LBM-A and LBM-BEI measure-
ments are possibly influenced by volume overload.13,14 High
ECW/TBW value has been confirmed to reflect fluid overload
and to be associated with decreased technique survival;16
therefore, we used this parameter as an indicator of the
volume status and adjusted it in our study.
Our results revealed that LBM measured by CK, A, and
BEI was not related to the visceral protein indices and to the
protein and energy intake, and there was a minor but
insignificant correlation between LBM and SGA. Only HGS,
which is a good marker of the somatic protein store,
exhibited a strong correlation with LBM measured by the
three methods; this was similar to the results of the study by
Heimburger and Wang et al.8,17 The reason for no correlation
between LBM-CK and DPI should be investigated. Theo-
retically, dietary proteins exert an important influence on
creatinine excretion and consequently on LBM-CK measure-
ment.18,19,25 It has been hypothesized that different residual
renal function (RRF) and dialysis doses lead to different levels
of creatinine excretion despite similar protein intake levels,
thus resulting in different LBM-CK values.
Another aim of our study was to clarify whether LBM
measured by the three methods can predict the outcome of
PD patients. A nutritional index is considered to be valuable
if it can predict death in PD patients. For example, in
previous studies, serum Alb, PA, and creatinine levels and
SGA were confirmed to be predictors of death in PD patients;
therefore, they are considered to be significant and valuable
nutritional markers.1,2 As stated in the introduction, only a
few studies have included LBM as a parameter in logistic
regression survival models involving dialysis patients.9–11
To date, this is the fifth study to observe the prognostic role
of baseline LBM-CK values in the outcome of PD patients.
However, there are three points of difference between our
study and previous studies. First, we combined many
recognized prognostic factors with LBM in survival models
involving a large PD patient population. Second, only a single
nutritional index was considered in each model in order to
easily determine its predictive effect. Third, based on
previous literature, whether LBM-A and LBM-BEI have
similar roles in predicting death is unclear.
Our data demonstrated that decreased LBM-CK is a
significant predictor of death, while LBM-A and LBM-BEI
are not predictors of death following adjustment by age, sex,
body mass index (BMI), DM, CVD, RRF, Kt/V (weekly urea
clearance), total creatinine clearance (Tccr), CRP, cCaP, intact
parathyroid hormone (iPTH), ECW/TBW, normalized ECW
(nECW), and MAP. The possible reasons for this are as
follows. First, LBM-CK is a marker of the somatic protein
store, similar to the Scr and creatinine indices, which have
been confirmed as strong prediction factors for PD patients
in other reports.2,26,27 Second, previous studies have
suggested that LBM-CK measurement was unaffected by a
patient’s fluid status;15 therefore, the Dialysis Outcome
Quality Initiative guidelines recommend routine use of the
CK method.28 Third, Johansson18 reported that as compared
to measurement of the total body potassium, LBM-CK
significantly underestimated LBM by 2–14 kg. Further, as
compared to the antipyrine distribution volume, which is the
gold standard for measuring LBM, LBM-CK underestimated
LBM by 6.9 kg.3 It should be considered that the correlation
between LBM-CK and the outcome of CAPD patients may be
related to the fact that this method, as mentioned earlier,
underestimates the LBM and may falsely indicate patients as
malnourished. Fourth, LBM-BEI is calculated based on the
TBW measurement; thus, the LBM may be overestimated in a
patient suffering from fluid overload.13 This may explain why
although the LBM measured by BEI was high, there was no
significant difference in the patient outcome. Fifth, LBM-A,
Table 6 | Insignificant variables at the ‘enrollment’ point of PD excluded in three models by the multiple Cox proportional
regression analysis
Variables in model 1 b P Variables in model 2 b P Variables in model 3 b P
Age 0.065 0.799 Age 0.428 0.513 Age 0.529 0.467
BMI 0.072 0.789 BMI 0.144 0.705 BMI 0.177 0.674
CVD 0.194 0.660 CVD 0.224 0.636 CVD 0.129 0.720
DM 0.020 0.888 DM 0.101 0.751 DM 0.054 0.816
RRF 0.186 0.666 RRF 0.074 0.785 RRF 0.070 0.791
Kt/V 0.001 0.977 Kt/V 0.014 0.905 Kt/V 0.017 0.898
Tccr 0.126 0.723 Tccr 0 0.998 Tccr 0 0.999
CRP 2.764 0.096 CRP 2.102 0.147 CRP 2.303 0.129
iPTH 2.169 0.141 iPTH 1.332 0.248 iPTH 1.485 0.223
ECW/TBW 0.218 0.641 ECW/TBW 1.188 0.276 ECW/TBW 1.261 0.261
nECW 0.128 0.712 nECW 1.345 0.213 nECW 1.178 0.287
LBM-A 0.185 0.667 LBM-BIA 1.685 0.194
BMI, body mass index; CVD, cardiovascular disease; CRP, C-reactive protein; DM, diabetes mellitus; ECW/TBW, extracellular water/total body water; iPTH , intact parathyroid
hormone; Kt/V, weekly urea clearance; LBM-A, lean body mass-anthropometry; LBM-BEI, lean body mass-bioelectrical impedance; nECW, normalized extracellular water; RRF,
residual renal function; Tccr, total creatine clearance rate.
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which is an operator-dependent method, may not be
sufficiently sensitive to predict death in dialysis patients
because Nelson et al.29 observed no visible difference in the
triceps and subscapular skinfolds between age-, sex-, and
race-matched healthy controls and CAPD patients. In
addition, the equation by which LBM-A was calculated in
our study was developed for patients from the UK and may
not have been appropriate for Chinese patients.
The next point is why the baseline single values of LBM-
CK can predict the outcome of PD patients. As reported by
Johansson et al.,18 LBM-CK values may be influenced
by several factors, including dietary meat intake, physical
activity, hormonal balance, diurnal glomerular filtration rate
variations, and catabolic states; this would explain the
unacceptable high coefficient of variation observed for
LBM, that is, 14.2%. For this reason, repeated examinations
should be conducted over several days in order to minimize
the effects of ‘timing errors,’ and this reduces the convenience
of this method for standard use. However, recently, Trivedi
et al.9 provided a good explanation as to why single values of
LBM play an important role in the outcome; they reported
that death could be predicted in PD patients based on both
the baseline value and the weighted time average of LBM-CK
This suggests that the baseline single values and the weighted
time average values of LBM-CK are similar for most PD
patients. In our study, the variation in the LBM-CK
was relatively minor, probably because the follow-up time
was only two and a half years. Therefore, serial monitoring
should be recommended instead of a single LBM-CK
measurement in each PD patient in order to reduce the
systemic errors in LBM measurement occurring in most
centers and thus better determine variations in the somatic
protein store.30,31
Our study posed certain limitations. First, the study was
based on observations, and the follow-up time was relatively
short. Second, the role of LBM-CK in predicting survival was
not evaluated using the gold standard of LBM. Furthermore,
this study was conducted at a single center; therefore, the
case-mix characteristics may not have been representative of
the general PD population.
In conclusion, our results revealed that the LBM measured
by CK, A, and BEI correlated well with the somatic protein
store but not with other nutritional indicators of the visceral
protein store (serum Alb, PA, and transferrin) and with the
dietary nutrient intake. Further, LBM-CK but not LBM-A
and LBM-BEI could predict death in PD patients. Therefore,
LBM-CK can be considered as a more valuable method for
examining LBM to estimate the outcome in PD patients.
MATERIALS AND METHODS
Patient selection and follow-up
This study comprised 210 patients in the third month of PD at the
PD centers of Peking University First Hospital; the patients were
enrolled from January 2002 to June 2005. Baseline demographic and
clinical data were collected, including data of age, sex, BMI, etiology
of end-stage renal disease, DM, and CVD. CVD included congestive
heart failure, angina pectoris, old myocardial infarction, and cerebral
infarction, as described in a previous study. The biochemical index,
dialysis adequacy, and general nutrition status of the 210 patients
were simultaneously examined during the third month of dialysis as
the enrollment values. Brachial blood pressure was measured by
using a standard method. Systolic and diastolic blood pressure were
recorded, and the MAP was calculated by using a standard method.
The patients were followed-up until November 2006. Follow-up was
censored on transplantation or transfer to hemodialysis. The end
point was death on PD. All the patients were dialyzed by using
glucose lactate-buffered PD solutions (Baxter Health Care Inc.,
Guangzhou, China).
Laboratory data
Biochemical index. Biochemical indexes were analyzed using
Hitachi chemistry analyzer, and include Alb, PA, transferrin , urea
nitrogen (BUN), creatinine, triglyceride (TG), cholesterol (TCHO),
calcium, and phosphate. cCaP was calculated. iPTH was determined
by the immunoradiometricassay.
Dialysis adequacy. Twenty-four-hour dialysate and urine
collection were performed to calculate the fluid removal and solute
clearances. RRF was estimated using the average renal clearance of
urea and creatinine. Kt/V and Tccr were calculated using standard
methods. The distribution volume of urea (V), which is generally
assumed to be equal to TBW, was calculated from the Watson
equation.
Inflammation marker. Serum high-sensitive CRP was mea-
sured by immune rate nephelometric analysis. The detection limit of
CRP was 0.06 mg l1. Serum CRPX3 mg l1 was seen to be
abnormal.
Subjective global assessment. SGA was performed to evaluate
the overall protein–energy nutritional status by experienced research
staff blinded to all clinical and biochemical variables of the
patients.10 On the basis of evaluation, each patient was scored as
1¼ normal, 2¼mild to moderate malnourished, and 3¼ severe
malnourished.
Protein and energy intake. A continuous 3-day dietary was
recorded on a self-completed food diary. Then, DPI and dietery
energy intake were calculated and normalized for actual body
weight. The total calorie intake includes intake from dietary and
dialysate.
Hand grip strength (HGS). HGS was evaluated in both the
dominant and non-dominant arm using the dynamometer, which
was repeated three times and the greatest value was recorded in
Newton (N).
LBM. (1) LBM-CK: LBM was measured by the creatinine
kinetics method as described below. Dialysate and urine collections
for a 24-h period were obtained, and urea and creatinine in
dialysate, urine, and serum were examined at the same time. LBM-
CK was calculated according to the formula recommended by
Blake:32
LBM  CK ¼ 7:38 þ 3:29ðCE þ CDÞ
where CE is creatinine excretion in millimoles per day and CD is
creatinine degradation in millimoles per day. Creatinine excretion
and degradation were calculated using the formulas
CE ¼ UCO þ DCO
CD ¼ 0:04PCbody weight
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where UCO is the urinary creatinine output in millimoles per day,
DCO is the dialysate creatinine output in millimoles per day, and PC
is the plasma creatinine in micromoles per liter.
(2) LBM-A: Anthropometric measurements were taken in
millimeters by trained observers using standard skin-fold calipers.
The observers were blinded from the results obtained by applying
the creatinine kinetics formula. Measurements included biceps,
triceps, subscapular, and supra-iliac skin-fold thickness. For each
site, the observers obtained three readings, the average value of
which was used for further calculations. Lean body mass (in
kilograms) by the anthropometric method (LBM-A) was computed
using standard formulas:19
total skin fold ¼ biceps þ triceps þ subscapular þ suprailiac
body density ðmaleÞ ¼ 1:161  ½0:0632 log ðtotal skin foldÞ
body density ðfemaleÞ ¼ 1:1581  ½0:072 log ðtotal skin foldÞ
% body fat ¼ ½ð4:95=body densityÞ  4:5100
LBM  A ¼ body weightð1 % body fat=100Þ
(3) LBM-BEI: Multiple-frequency bioelectrical impedance ana-
lysis was performed using the hydra analyzis (Xitron Technologies,
San Diego, CA, USA). The procedure is described in detail
elsewhere. Briefly, after a patient drained the dialysate and was in
a supine position for at least 10 min, the standard tetrapolar
electrodes were placed on the dorsum of the wrist and anterior
aspect of the ankle on the left side of the body. Three consecutive
measurements were performed during a 2-min period, with
recording of values for ECW, intracellular water , and TBW. Height
nECW was calculated. Resistance values obtained were then used to
calculate LBM using a software package provided by the manu-
facturer.
LBM-CK, LBM-A, and LBM-BEI were all normalized to ideal
body weight (IBW, IBW¼height (cm)105) and subsequently
represented as %LBM-CK, %LBM-A, and %LBM-BEI.
Statistical analyses
Statistical analysis was performed using the SPSS software, version
11.0 (SPSS Inc., Chicago, IL, USA). Continuous variables were
expressed as the mean value±s.d., whereas categorical variables
were expressed as a percentage or ratio. Partial correlation analysis
was used to analyze the relationship of the LBM measured by the
three methods adjusted by sex, CRP, and ECW/TBW, respectively,
with other nutritional parameters. Recognized outcome predictors
combined with LBM-CK, LBM-A, or LBM-BEI were considered in
Cox proportional regression (forward conditional) models to
determine whether LBM measured by the three methods could
predict the outcome. Thus, three Cox proportional regression
models were constructed. In model 1, the variables included age, sex,
BMI, DM, CVD, RRF, Kt/V, Tccr, CRP, cCaP, iPTH, ECW/TBW,
nECW, MAP, and LBM-CK. In model 2, they included age, sex,
BMI, DM, CVD, RRF, Kt/V, Tccr, CRP, cCaP, iPTH, ECW/TBW,
nECW, MAP, and LBM-A. In model 3, they included age, sex, BMI,
DM, CVD, RRF, Kt/V, Tccr, CRP, cCaP, iPTH, ECW/TBW, nECW,
MAP, and LBM-BEI. The final models comprised those variables
that remained in the model with a significance level of 0.05. Po0.05
indicated statistical significance.
DISCLOSURE
There are no interests to be disclosed.
ACKNOWLEDGMENTS
We thank all the nurses and renal dietitians in the Peritoneal Dialysis
Center of the First hospital, Peking University for their help. This work
was funded by National ‘211 project’ Peking University EBM group
(38–18).
REFERENCES
1. Canada–U.S.A (CANUSA) Peritoneal Dialysis Study Group. Adequacy of
dialysis and nutrition in continuous peritoneal dialysis: association with
clinical outcome. J Am Soc Nephrol 1996; 7: 198–207.
2. Lowrie EG, Huang WH, Lew NL. Death risk predictors among peritoneal
dialysis and hemodialysis patients: a preliminary comparison. Am J Kidney
Dis 1995; 26: 220–228.
3. de Fijter WM, de Fijter CWH, Oe PL et al. Assessment of total body water
and lean body mass from anthropometry, Watson formula, creatinine
kinetics and body electrical impedance compared with antipyrine kinetics
in peritoneal dialysis patients. Nephrol Dial Transplant 1997; 12: 151–156.
4. Kang DH, Yoon KI, Choi KB et al. Relationship of peritoneal membrane
transport characteristics to the nutritional status in CAPD patients.
Nephrol Dial Transplant 1999; 14: 1715–1722.
5. Bhatla B, Moore H, Emerson P et al. Lean body mass estimation by
creatinine kinetics, bioimpedance and dual energy X-ray absorptiometry
in patients on continuous ambulatory peritoneal dialysis. ASAIO J 1995;
41: M442–M446.
6. Keshaviah PR, Nolph KD, Moore HL et al. Lean body mass estimation by
creatinine kinetics. J Am Soc Nephrol 1994; 4: 1475–1485.
7. Szeto CC, Kong J, Alan KL et al. The role of lean body mass as a nutritional
index in Chinese peritoneal dialysis patients—comparison of creatinine.
Perit Dial Int 2000; 20: 708–714.
8. Heimburger O, Qureshi AR, Blaner WS et al. Hand-grip muscle strength,
lean body mass, and plasma proteins as markers of nutritional status in
patients with chronic renal failure close to start of dialysis therapy. Am J
Kidney Dis 2000; 36: 1213–1225.
9. Trivedi H, Tan SH, Prowant B et al. Predictors of death in patients on
peritoneal dialysis: the Missouri Peritoneal Dialysis Study. Am J Nephrol
2005; 25: 466–473.
10. Szeto CC, Wong TY, Leung CB et al. Importance of dialysis adequacy in
mortality and morbidity of Chinese CAPD patients. Kidney Int 2000; 58:
400–407.
11. Chung SH, Heimburger O, Stenvinkel P et al. Influence of peritoneal
transport rate, inflammation, and fluid removal on nutritional status and
clinical outcome in prevalent peritoneal dialysis patients. Perit Dial Int
2003; 23: 174–183.
12. Stenvinkel P, Barany P, Chung SH et al. A comparative analysis of
nutritional parameters as predictors of outcome in male and female ESRD
patients. Nephrol Dial Transplant 2002; 17: 1266–1274.
13. Konings CJ, Kooman JP, Schonck M et al. Influence of fluid status on
techniques used to assess body composition in peritoneal dialysis
patients. Perit Dial Int 2003; 23: 184–190.
14. Panzetta G, Guerra U, D’Angelo A. Body composition and nutritional
status in patients on continuous ambulatory peritoneal dialysis. Clin
Nephrol 1985; 23: 18–25.
15. Lo Wk, Prowant BF, Moore HL et al. Comparison of different
measurements of lean body mass in normal individuals and in chronic
peritoneal dialysis patients. Am J Kidney Dis 1994; 23: 74–85.
16. Jones CH, Newstead CG. The ratio of extracellular fluid to total body
water and technique survival in peritoneal dialysis patients. Perit Dial Int
2004; 24: 353–358.
17. Wang AYM, Sea MMM, Ho ZSY et al. Evaluation of handgrip strength as a
nutritional marker and prognostic indicator in peritoneal dialysis patients.
Am J Clin Nutr 2005; 81: 79–86.
18. Johansson AC, Attman PO, Haraldsson B. Creatinine generation rate and
lean body mass: a critical analysis in peritoneal dialysis patients. Kidney Int
1997; 51: 855–859.
19. Crim MC, Calloway DH, Margen S. Creatine metabolism in men: urinary
creatine and creatinine excretions with creatine feeding. J Nutr 1975; 105:
428–438.
20. Desmeules S, Levesque R, Jaussent I et al. Creatinine index and lean body
mass are excellent predictors of long-term survival in haemodiafiltration
patients. Nephrol Dial Transplant 2004; 19: 1182–1189.
21. Avram MM, Goldwasser P, Erroa M. Predictors of survival in continuous
ambulatory peritoneal dialysis patients. The importance of prealbumin
and other nutritional and metabolic markers. Am J Kidney Dis 1994; 23:
91–98.
Kidney International (2008) 73, 334–340 339
J Dong et al.: Correlations of LBM with nutritional indicators and mortality o r i g i n a l a r t i c l e
22. Han DS, Lee SW, Kang SW et al. Factors affecting low values of serum
albumin in CAPD patients. Adv Perit Dial 1996; 12: 288–292.
23. Kaysen GA, Rathore V, Shearer GC et al. Mechanisms of hypoalbuminemia
in hemodialysis patients. Kidney Int 1995; 48: 510–516.
24. Gabay C, Kushner I. Acute-phase proteins and other systemic responses
to inflammation. N Engl J Med 1999; 340: 448–454.
25. Bleiler RE, Schedl HP. Creatinine excretion: variability and relationships to
diet and body size. J Lab Clin Med 1962; 59: 945–955.
26. Desmeules S, Levesque R, Jaussent I et al. Creatinine index and
lean body mass are excellent predictors of long-term survival in
haemodiafiltration patients. Nephrol Dial Transplant 2004; 19:
1182–1189.
27. Avram MM, Goldwasser P, Erroa M. Predictors of survival in continuous
ambulatory peritoneal dialysis patients. The importance of prealbumin
and other nutritional and metabolic markers. Am J Kidney Dis 1994; 23:
91–98.
28. National Kidney Foundation Dialysis Outcomes Quality Initiative.
Assessment of nutritional status specifically as it relates to peritoneal
dialysis. Am J Kidney Dis 1997; 30(Suppl 2): S83–S85.
29. Nelson EE, Hong CD, Pesce AL et al. Anthropometric norms for the
dialysis population. Am J Kidney Dis 1990; 16: 32–37.
30. Kopple JD, Wolfson M, Chertow GM et al. K/DOQI nutrition in chronic
renal failure [J]. Am J Kidney Dis 2000; 35(6 Suppl 2): s17–s18.
31. Perea RA, Blake PG, Spanner E et al. High creatinine excretion ratio
predicts a good outcome in peritoneal dialysis patients. Am J Kidney Dis
2000; 36: 362–367.
32. Blake PG, Bargman JM, Bick J et al. Guidelines for adequacy and nutrition
in peritoneal dialysis. J Am Soc Nephrol 1999; 10: 5287–5321.
340 Kidney International (2008) 73, 334–340
o r i g i n a l a r t i c l e J Dong et al.: Correlations of LBM with nutritional indicators and mortality
